Drug CarriersDeoxycytidineAntimetabolites, AntineoplasticDrug Delivery SystemsNanoparticlesPancreatic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsParticle SizeDeoxycytidine KinaseChitosanChemistry, PharmaceuticalLiposomesPolyethylene GlycolsNanomedicineCarrier StateFractionation, Field FlowNanocapsulesTechnology, PharmaceuticalAconitic AcidDrug CompoundingPolymersCell Line, TumorCisplatinDendrimersCellulose, OxidizedPolyglactin 910Drug Administration SchedulePoloxamerBiliary Tract NeoplasmsEmulsionsAntineoplastic AgentsDelayed-Action PreparationsDoxorubicinTreatment OutcomeTissue DistributionMicellesNanotechnologyLung NeoplasmsNanostructuresInfusions, IntravenousEquilibrative Nucleoside Transporter 1Carcinoma, Non-Small-Cell LungAdenocarcinomaDose-Response Relationship, DrugSolubilityPaclitaxelPolyestersCarrier ProteinsVinblastineNeoplasmsMice, NudeMaximum Tolerated DoseCapsulesDrug Resistance, NeoplasmAcrylamidesMicrospheresTaxoidsPoly IPowder DiffractionAcyl Carrier ProteinCarcinoma, Pancreatic DuctalCalorimetry, Differential ScanningCell SurvivalAntibiotics, AntineoplasticSurface-Active AgentsPolyglycolic AcidHeterozygote DetectionExcipientsDrug SynergismLead RadioisotopesDisease-Free SurvivalPowdersXenograft Model Antitumor AssaysRibonucleoside Diphosphate ReductaseSurface PropertiesNeutropeniaOrganoplatinum CompoundsFluorouracilHeterozygoteBiocompatible MaterialsCarboplatinRadiation-Sensitizing AgentsMagneticsSurvival RateUrologic NeoplasmsCA-19-9 AntigenReduced Folate Carrier ProteinDrug StabilityCombined Modality TherapyCarcinoma, Transitional CellBiological AvailabilityMicrobubblesMetal NanoparticlesNeoplasm MetastasisSerum AlbuminThrombocytopeniaGallbladder NeoplasmsUrinary Bladder NeoplasmsGuanineNeoplasm Staging